Antiphospholipid syndrome (APS) is a thrombo-inflammatory disease propelled by
circulating autoantibodies that recognize cell surface phospholipids and phospholipid …

The antiphospholipid syndrome (APS) is an autoimmune disease characterized by the
occurrence of venous and/or arterial thrombosis and pregnancy morbidity in the presence of …

The objective was to develop evidence-based recommendations for the management of
antiphospholipid syndrome (APS) in adults. Based on evidence from a systematic literature …

The aim of this updated statement is to provide comprehensive and timely evidence-based
recommendations on the prevention of stroke among individuals who have not previously …

Guidelines Committee and the sounding board of BSH. It was also placed on the members
section of the BSH website for comment. It has also been reviewed by Royal College of …

Persistent antiphospholipid (aPL) antibodies are occasionally found in subjects without prior
history of thromboembolic events (TEs), raising the dilemma of whether to initiate or not a …

Background Sporadic studies suggest hydroxychloroquine (HCQ) may be effective for
thrombosis prevention in patients with primary antiphospholipid syndrome (PAPS) and may …

We performed a meta-analysis to determine whether aspirin has a significant protective
effect on risk of first thrombosis among patients with antiphospholipid antibodies (aPL+) …

Antiphospholipid antibodies are a heterogeneous group of autoantibodies that have clear
associations with thrombosis and pregnancy morbidity, and which together constitute the …

Antiphospholipid syndrome (APS) is an autoantibody-mediated acquired thrombophilia. It is
characterized by the presence of antiphospholipid antibodies (APL) that are directed against …